Breaking News Instant updates and real-time market news.

ZURVY

Zurich Insurance

$0.00 /

+ (+0.00%)

14:13
06/11/20
06/11
14:13
06/11/20
14:13

Zurich Insurance price target lowered to CHF 405 from CHF 410 at Barclays

Barclays analyst Claudia Gaspari lowered the firm's price target on Zurich Insurance to CHF 405 from CHF 410 and keeps an Overweight rating on the shares.

ZURVY Zurich Insurance
$0.00 /

+ (+0.00%)

06/07/20 Goldman Sachs
Zurich Insurance upgraded to Conviction Buy from Buy at Goldman Sachs
05/28/20 BofA
Zurich Insurance price target raised to CHF 370 from CHF 360 at BofA
05/22/20 Kepler Cheuvreux
Zurich Insurance upgraded to Buy from Hold at Kepler Cheuvreux
05/15/20 JPMorgan
Zurich Insurance price target lowered to CHF 370 from CHF 410 at JPMorgan

TODAY'S FREE FLY STORIES

Recommendations
Arena Pharmaceuticals price target raised to $78 from $60 at Wells Fargo » 08:30
08/06/20
08/06
08:30
08/06/20
08:30
ARNA

Arena Pharmaceuticals

$64.22 /

+0.66 (+1.04%)

Wells Fargo analyst Jim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARNA Arena Pharmaceuticals
$64.22 /

+0.66 (+1.04%)

ARNA Arena Pharmaceuticals
$64.22 /

+0.66 (+1.04%)

07/27/20 Citi
Arena Pharmaceuticals price target raised to $83 from $65 at Citi
06/29/20 H.C. Wainwright
Arena Pharmaceuticals initiated with a Buy at H.C. Wainwright
06/02/20 Credit Suisse
Arena Pharmaceuticals price target raised to $87 from $77 at Credit Suisse
06/02/20 Cantor Fitzgerald
Arena Pharmaceuticals price target raised to $88 from $68 at Cantor Fitzgerald
ARNA Arena Pharmaceuticals
$64.22 /

+0.66 (+1.04%)

  • 28
    May
ARNA Arena Pharmaceuticals
$64.22 /

+0.66 (+1.04%)

Options
One new option listing and one option delisting on August 6th » 08:30
08/06/20
08/06
08:30
08/06/20
08:30
ROYT

Pacific Coast Oil

/

+

New option listings for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ROYT Pacific Coast Oil
/

+

Earnings
Kimbell Royalty Partners reports Q2 EPS ($1.39), consensus (10c) » 08:29
08/06/20
08/06
08:29
08/06/20
08:29
KRP

Kimbell Royalty Partners

$9.04 /

+0.14 (+1.57%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KRP Kimbell Royalty Partners
$9.04 /

+0.14 (+1.57%)

KRP Kimbell Royalty Partners
$9.04 /

+0.14 (+1.57%)

07/07/20 TD Securities
Kimbell Royalty Partners initiated with a Buy at TD Securities
04/22/20 Imperial Capital
Kimbell Royalty Partners price target lowered to $7 from $15 at Imperial Capital
03/19/20 Credit Suisse
Kimbell Royalty Partners assumed with an Outperform at Credit Suisse
01/22/20 KeyBanc
Kimbell Royalty Partners initiated with an Overweight at KeyBanc
KRP Kimbell Royalty Partners
$9.04 /

+0.14 (+1.57%)

  • 10
    Jan
Recommendations
Ceridian price target raised to $94 from $70 at Needham » 08:29
08/06/20
08/06
08:29
08/06/20
08:29
CDAY

Ceridian

$84.27 /

+1.88 (+2.28%)

Needham analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CDAY Ceridian
$84.27 /

+1.88 (+2.28%)

CDAY Ceridian
$84.27 /

+1.88 (+2.28%)

06:43 Today Mizuho
Ceridian price target raised to $100 from $85 at Mizuho
06:01 Today CIBC
Ceridian downgraded to Neutral on near term headwinds at CIBC
05:27 Today CIBC
Ceridian downgraded to Neutral from Outperformer at CIBC
06/29/20 Goldman Sachs
Ceridian price target raised to $72 from $62 at Goldman Sachs
CDAY Ceridian
$84.27 /

+1.88 (+2.28%)

  • 09
    Jun
  • 21
    May
  • 13
    Nov
  • 05
    Sep
  • 07
    Aug
CDAY Ceridian
$84.27 /

+1.88 (+2.28%)

Hot Stocks
Catalyst Pharmaceuticals' Firdapse receives marketing approval in Canada » 08:29
08/06/20
08/06
08:29
08/06/20
08:29
CPRX

Catalyst Pharmaceuticals

$4.13 /

+0.005 (+0.12%)

Catalyst Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPRX Catalyst Pharmaceuticals
$4.13 /

+0.005 (+0.12%)

CPRX Catalyst Pharmaceuticals
$4.13 /

+0.005 (+0.12%)

11/13/19 Piper Jaffray
Catalyst Pharmaceuticals price target lowered to $7 from $8 at Piper Jaffray
10/09/19 Piper Jaffray
Catalyst should see limited impact from Ruzurgi launch, says Piper Jaffray
08/08/19 Cantor Fitzgerald
Catalyst price target raised to $12 from $10 at Cantor Fitzgerald
08/08/19 SunTrust
SunTrust says buy Catalyst on weakness, boosts price target to $11
CPRX Catalyst Pharmaceuticals
$4.13 /

+0.005 (+0.12%)

  • 13
    Sep
CPRX Catalyst Pharmaceuticals
$4.13 /

+0.005 (+0.12%)

Recommendations
Nexstar price target raised to $122 from $115 at B. Riley FBR » 08:29
08/06/20
08/06
08:29
08/06/20
08:29
NXST

Nexstar

$86.12 /

-2.77 (-3.12%)

B. Riley FBR analyst Zack…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NXST Nexstar
$86.12 /

-2.77 (-3.12%)

NXST Nexstar
$86.12 /

-2.77 (-3.12%)

06/22/20 Benchmark
Nexstar price target raised to $125 from $120 at Benchmark
05/07/20 Wells Fargo
Nexstar price target raised to $88 from $81 at Wells Fargo
05/07/20 B. Riley FBR
Nexstar price target raised to $115 from $110 at B. Riley FBR
05/05/20 B. Riley FBR
Nexstar price target lowered to $110 from $139 at B. Riley FBR
NXST Nexstar
$86.12 /

-2.77 (-3.12%)

Recommendations
Medifast price target raised to $220 from $164 at B. Riley FBR » 08:28
08/06/20
08/06
08:28
08/06/20
08:28
MED

Medifast

$183.22 /

+8.89 (+5.10%)

B. Riley FBR analyst Kara…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MED Medifast
$183.22 /

+8.89 (+5.10%)

MED Medifast
$183.22 /

+8.89 (+5.10%)

06/25/20 B. Riley FBR
Medifast initiated with a Buy at B. Riley FBR
02/27/20 DA Davidson
Medifast price target raised to $83 from $74 at DA Davidson
02/27/20 Jefferies
Medifast downgraded to Hold from Buy at Jefferies
01/14/20 Jefferies
Medifast price target raised to $130 from $110 at Jefferies
MED Medifast
$183.22 /

+8.89 (+5.10%)

MED Medifast
$183.22 /

+8.89 (+5.10%)

Hot Stocks
Safe Bulkers adopts shareholder rights plan » 08:28
08/06/20
08/06
08:28
08/06/20
08:28
SB

Safe Bulkers

$1.25 /

-0.065 (-4.96%)

Safe Bulkers, announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SB Safe Bulkers
$1.25 /

-0.065 (-4.96%)

SB Safe Bulkers
$1.25 /

-0.065 (-4.96%)

07/29/20 DNB Markets
Safe Bulkers upgraded to Buy from Hold at DNB Markets
SB Safe Bulkers
$1.25 /

-0.065 (-4.96%)

Earnings
Shift4 Payments sees Q4 revenue $75M-$79M » 08:28
08/06/20
08/06
08:28
08/06/20
08:28
FOUR

Shift4 Payments

$39.10 /

-0.24 (-0.61%)

Sees Q4 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOUR Shift4 Payments
$39.10 /

-0.24 (-0.61%)

FOUR Shift4 Payments
$39.10 /

-0.24 (-0.61%)

07/10/20 Compass Point
Compass Point sees near and long term risks for Shift4 Payments, starts at Sell
07/09/20 Compass Point
Shift4 Payments initiated with a Sell at Compass Point
07/01/20 Citi
Shift4 Payments initiated with a Neutral at Citi
06/30/20 Morgan Stanley
Shift4 Payments initiated with an Equal Weight at Morgan Stanley
FOUR Shift4 Payments
$39.10 /

-0.24 (-0.61%)

  • 05
    Jun
FOUR Shift4 Payments
$39.10 /

-0.24 (-0.61%)

FOUR Shift4 Payments
$39.10 /

-0.24 (-0.61%)

Upgrade
TCG BDC upgraded to Equal Weight at Wells Fargo » 08:27
08/06/20
08/06
08:27
08/06/20
08:27
CGBD

TCG BDC

$9.03 /

+0.64 (+7.63%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CGBD TCG BDC
$9.03 /

+0.64 (+7.63%)

04:44 Today Wells Fargo
TCG BDC upgraded to Equal Weight from Underweight at Wells Fargo
05/11/20 Citi
TCG BDC price target raised to $9 from $7 at Citi
02/11/20 Wells Fargo
TCG BDC downgraded to Underweight from Equal Weight at Wells Fargo
09/05/19 Keefe Bruyette
TCG BDC downgraded to Market Perform from Outperform at Keefe Bruyette
CGBD TCG BDC
$9.03 /

+0.64 (+7.63%)

Earnings
Newmark not providing 2020 guidance » 08:27
08/06/20
08/06
08:27
08/06/20
08:27
NMRK

Newmark

$4.20 /

+0.175 (+4.35%)

Newmark is not providing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NMRK Newmark
$4.20 /

+0.175 (+4.35%)

NMRK Newmark
$4.20 /

+0.175 (+4.35%)

04/09/20 BofA
Newmark double-downgraded to Underperform from Buy at BofA
04/09/20 BofA
Newmark downgraded to Underperform from Buy at BofA
02/14/20 Wedbush
Newmark downgraded to Neutral from Outperform at Wedbush
02/14/20 Piper Sandler
Newmark downgraded to Neutral from Overweight at Piper Sandler
NMRK Newmark
$4.20 /

+0.175 (+4.35%)

Hot Stocks
Monro CEO Brett Ponton to step down » 08:27
08/06/20
08/06
08:27
08/06/20
08:27
MNRO

Monro

$59.43 /

+0.94 (+1.61%)

Monro announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MNRO Monro
$59.43 /

+0.94 (+1.61%)

MNRO Monro
$59.43 /

+0.94 (+1.61%)

05/29/20 Guggenheim
Monro downgraded to Neutral on slower recovery expectations at Guggenheim
05/29/20 Guggenheim
Monro downgraded to Neutral from Buy at Guggenheim
04/03/20 SunTrust
Monro price target lowered to $47 from $68 at SunTrust
12/10/19
Fly Intel: Top five analyst upgrades
MNRO Monro
$59.43 /

+0.94 (+1.61%)

Earnings
Shift4 Payments sees Q3 revenue $74M-$78M, consensus $92.96M » 08:27
08/06/20
08/06
08:27
08/06/20
08:27
FOUR

Shift4 Payments

$39.10 /

-0.24 (-0.61%)

Sees Q3 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOUR Shift4 Payments
$39.10 /

-0.24 (-0.61%)

FOUR Shift4 Payments
$39.10 /

-0.24 (-0.61%)

07/10/20 Compass Point
Compass Point sees near and long term risks for Shift4 Payments, starts at Sell
07/09/20 Compass Point
Shift4 Payments initiated with a Sell at Compass Point
07/01/20 Citi
Shift4 Payments initiated with a Neutral at Citi
06/30/20 Morgan Stanley
Shift4 Payments initiated with an Equal Weight at Morgan Stanley
FOUR Shift4 Payments
$39.10 /

-0.24 (-0.61%)

  • 05
    Jun
FOUR Shift4 Payments
$39.10 /

-0.24 (-0.61%)

FOUR Shift4 Payments
$39.10 /

-0.24 (-0.61%)

Recommendations
Extreme Networks price target raised to $9 from $7.50 at B. Riley FBR » 08:26
08/06/20
08/06
08:26
08/06/20
08:26
EXTR

Extreme Networks

$5.02 /

+0.27 (+5.68%)

B. Riley FBR analyst Dave…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EXTR Extreme Networks
$5.02 /

+0.27 (+5.68%)

EXTR Extreme Networks
$5.02 /

+0.27 (+5.68%)

07/21/20 B. Riley FBR
HP Enterprise deal shows Extreme Networks undervalued, says B. Riley FBR
07/15/20 B. Riley FBR
B. Riley starts Extreme Networks at Buy, calls 'best pure networking play'
07/14/20 B. Riley FBR
Extreme Networks initiated with a Buy at B. Riley FBR
06/04/20 Lake Street
Extreme Networks price target raised to $5 from $4 at Lake Street
EXTR Extreme Networks
$5.02 /

+0.27 (+5.68%)

EXTR Extreme Networks
$5.02 /

+0.27 (+5.68%)

Earnings
Newmark reports Q2 adjusted EPS 10c, consensus 19c » 08:26
08/06/20
08/06
08:26
08/06/20
08:26
NMRK

Newmark

$4.20 /

+0.175 (+4.35%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NMRK Newmark
$4.20 /

+0.175 (+4.35%)

NMRK Newmark
$4.20 /

+0.175 (+4.35%)

04/09/20 BofA
Newmark double-downgraded to Underperform from Buy at BofA
04/09/20 BofA
Newmark downgraded to Underperform from Buy at BofA
02/14/20 Wedbush
Newmark downgraded to Neutral from Outperform at Wedbush
02/14/20 Piper Sandler
Newmark downgraded to Neutral from Overweight at Piper Sandler
NMRK Newmark
$4.20 /

+0.175 (+4.35%)

Earnings
Sutro Biopharma reports Q2 EPS (94c), consensus (64c) » 08:26
08/06/20
08/06
08:26
08/06/20
08:26
STRO

Sutro Biopharma

$8.42 /

-0.08 (-0.94%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STRO Sutro Biopharma
$8.42 /

-0.08 (-0.94%)

STRO Sutro Biopharma
$8.42 /

-0.08 (-0.94%)

07/16/20 Wells Fargo
Sutro Biopharma initiated with an Overweight at Wells Fargo
05/17/20 Piper Sandler
Sutro Biopharma price target lowered to $20 from $23 at Piper Sandler
01/13/20 SunTrust
Sutro Biopharma initiated with a Buy at SunTrust
10/07/19
Fly Intel: Top five analyst initiations
STRO Sutro Biopharma
$8.42 /

-0.08 (-0.94%)

  • 12
    May
Downgrade
Oasis Petroleum downgraded to Neutral from Buy at MKM Partners » 08:26
08/06/20
08/06
08:26
08/06/20
08:26
OAS

Oasis Petroleum

$0.76 /

+0.0764 (+11.24%)

MKM Partners analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OAS Oasis Petroleum
$0.76 /

+0.0764 (+11.24%)

OAS Oasis Petroleum
$0.76 /

+0.0764 (+11.24%)

06:15 Today MKM Partners
Oasis Petroleum downgraded to Neutral from Buy at MKM Partners
06/09/20 Citi
Oasis Petroleum downgraded to Sell from Neutral at Citi
06/09/20 Citi
Oasis Petroleum downgraded to Sell from Neutral at Citi
05/01/20 Tudor Pickering
Oasis Petroleum downgraded to Sell from Hold at Tudor Pickering
OAS Oasis Petroleum
$0.76 /

+0.0764 (+11.24%)

OAS Oasis Petroleum
$0.76 /

+0.0764 (+11.24%)

OAS Oasis Petroleum
$0.76 /

+0.0764 (+11.24%)

OAS Oasis Petroleum
$0.76 /

+0.0764 (+11.24%)

Downgrade
Inseego downgraded to Market Perform on valuation at Northland » 08:25
08/06/20
08/06
08:25
08/06/20
08:25
INSG

Inseego

$14.76 /

+0.23 (+1.58%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INSG Inseego
$14.76 /

+0.23 (+1.58%)

INSG Inseego
$14.76 /

+0.23 (+1.58%)

08:13 Today Northland
Inseego downgraded to Market Perform from Outperform at Northland
07:59 Today Roth Capital
Inseego downgraded to Neutral from Buy at Roth Capital
06/25/20 Stifel
Inseego initiated with a Buy at Stifel
05/19/20 Cowen
Inseego price target raised to $13.50 from $12 at Cowen
INSG Inseego
$14.76 /

+0.23 (+1.58%)

INSG Inseego
$14.76 /

+0.23 (+1.58%)

INSG Inseego
$14.76 /

+0.23 (+1.58%)

Hot Stocks
Oxford Lane sees NAV $3.25-$3.35 as of July 31 » 08:25
08/06/20
08/06
08:25
08/06/20
08:25
OXLC

Oxford Lane

$4.62 /

-0.015 (-0.32%)

Management's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OXLC Oxford Lane
$4.62 /

-0.015 (-0.32%)

OXLC Oxford Lane
$4.62 /

-0.015 (-0.32%)

OXLC Oxford Lane
$4.62 /

-0.015 (-0.32%)

Hot Stocks
AstraZeneca enters clinical trial collaboration with Daiichi Sankyo » 08:25
08/06/20
08/06
08:25
08/06/20
08:25
AZN

AstraZeneca

$55.92 /

-0.145 (-0.26%)

Daiichi Sankyo announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$55.92 /

-0.145 (-0.26%)

AZN AstraZeneca
$55.92 /

-0.145 (-0.26%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/31/20 Barclays
Barclays backs Overweight on AstraZeneca after Q2 results
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/29/20 Barclays
AstraZeneca price target raised to 9,300 GBp from 9,200 GBp at Barclays
AZN AstraZeneca
$55.92 /

-0.145 (-0.26%)

AZN AstraZeneca
$55.92 /

-0.145 (-0.26%)

AZN AstraZeneca
$55.92 /

-0.145 (-0.26%)

AZN AstraZeneca
$55.92 /

-0.145 (-0.26%)

Earnings
Shift4 Payments reports Q2 EPS (3c), consensus (10c) » 08:25
08/06/20
08/06
08:25
08/06/20
08:25
FOUR

Shift4 Payments

$39.10 /

-0.24 (-0.61%)

Reports Q2 revenue $141M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOUR Shift4 Payments
$39.10 /

-0.24 (-0.61%)

FOUR Shift4 Payments
$39.10 /

-0.24 (-0.61%)

07/10/20 Compass Point
Compass Point sees near and long term risks for Shift4 Payments, starts at Sell
07/09/20 Compass Point
Shift4 Payments initiated with a Sell at Compass Point
07/01/20 Citi
Shift4 Payments initiated with a Neutral at Citi
06/30/20 Morgan Stanley
Shift4 Payments initiated with an Equal Weight at Morgan Stanley
  • 05
    Jun
FOUR Shift4 Payments
$39.10 /

-0.24 (-0.61%)

FOUR Shift4 Payments
$39.10 /

-0.24 (-0.61%)

Technical Analysis
DJ Transportation Average: Pivot points » 08:25
08/06/20
08/06
08:25
08/06/20
08:25
$DJT

DJ Transportation Average

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$DJT DJ Transportation Average
$0.00 /

+ (+0.00%)

$DJT DJ Transportation Average
$0.00 /

+ (+0.00%)

Earnings
Provention Bio reports Q2 EPS (45c), consensus (28c) » 08:25
08/06/20
08/06
08:25
08/06/20
08:25
PRVB

Provention Bio

$11.12 /

-0.13 (-1.16%)

"In the past few…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRVB Provention Bio
$11.12 /

-0.13 (-1.16%)

PRVB Provention Bio
$11.12 /

-0.13 (-1.16%)

06/16/20 H.C. Wainwright
Provention Bio price target raised to $26 from $20 at H.C. Wainwright
06/04/20
Fly Intel: Top five analyst initiations
06/04/20 RBC Capital
Provention Bio initiated with an Outperform at RBC Capital
06/03/20 Oppenheimer
Provention Bio initiated with an Outperform at Oppenheimer
PRVB Provention Bio
$11.12 /

-0.13 (-1.16%)

  • 18
    Jun
  • 19
    Sep
PRVB Provention Bio
$11.12 /

-0.13 (-1.16%)

Hot Stocks
Dick's Sporting to open 11 stores in 9 states in August » 08:25
08/06/20
08/06
08:25
08/06/20
08:25
DKS

Dick's Sporting

$46.83 /

+0.84 (+1.83%)

DICK'S Sporting…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DKS Dick's Sporting
$46.83 /

+0.84 (+1.83%)

DKS Dick's Sporting
$46.83 /

+0.84 (+1.83%)

08/04/20 Goldman Sachs
Dick's Sporting price target raised to $50 from $40 at Goldman Sachs
07/28/20 UBS
Dick's Sporting price target raised to $47 from $43 at UBS
06/24/20 Cowen
Dick's Sporting upgraded to Outperform from Market Perform at Cowen
06/19/20 UBS
Dick's Sporting price target raised to $43 from $40 at UBS
DKS Dick's Sporting
$46.83 /

+0.84 (+1.83%)

DKS Dick's Sporting
$46.83 /

+0.84 (+1.83%)

DKS Dick's Sporting
$46.83 /

+0.84 (+1.83%)

DKS Dick's Sporting
$46.83 /

+0.84 (+1.83%)

Technical Analysis
DJ Utility Average: Pivot points » 08:24
08/06/20
08/06
08:24
08/06/20
08:24
$DJU

DJ Utility Average

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$DJU DJ Utility Average
$0.00 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.